The heart-protective effects stem from semaglutide's action on GLP-1 receptors located directly in cardiac tissue
Left, ligand-induced changes in BRET were measured in plasma membrane preparations performed in kinetic mode until kinetic equilibrium with a saturating concentration of GLP-1 and TT-OAD2
While it generally produces less weight loss than newer agents such as tirzepatide, liraglutide remains an effective option for many patients, particularly those who may benefit from a daily medication or for whom other GLP-1 therapies are not appropriate
Semaglutide is a breakthrough treatment for type 2 diabetes and weight loss in people who are obese or overweight when combined with a healthy diet and exercise
Further investigations by Moody and Holst indicated that the peptide either was or constituted part of a proglucagon precursor because similar fragments could be found in the pancreas (Moody, Holst, Thim, Lindkaer, Jensen)
Wolraich, 2011)